Kali Therapeutics
PrivateLast Round
Strategic
Mar 23, 2026
Total Funding Raised
$180M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Kali Therapeutics operates in Healthcare & Life Sciences and is based in San Mateo, California. Its latest recorded funding round was a Strategic round in March 2026.
Kali Therapeutics is a biotechnology company that develops trispecific T-cell engager therapies designed to reset the immune system for the treatment of autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kali Therapeutics Comparables
Compare Kali Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Oblenio Bio | 91% | |
| Boulevard Bio | 89% | |
| Epana Bio | 83% |
For institutional investors. Book with your work email.
Kali Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Kali Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| LYFE Capital | Seed, Early Funding, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 2, 2026
Grew 38% QoQ from 8 to 11 employees.
- Jul 20, 2026
Grew 43% QoQ, from 7 to 10 employees.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- recognized_asSep 25, 2026
Kali Therapeutics, Inc is selected by the Endpoints News editorial team as a winner of the 2026 Endpoints 11, its annual list of the 11 most promising private biotechnology companies, announced in California on Sep 25th '26.
For institutional investors. Book with your work email.
Kali Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Kali Therapeutics's valuation, stock price, and market status.
Is Kali Therapeutics a public or private company?
Kali Therapeutics is a private company.
What is the current stock price of Kali Therapeutics?
Kali Therapeutics is a private company, so its shares have no public market price. Caplight tracks Kali Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Kali Therapeutics worth (valuation)?
Valuation information for Kali Therapeutics is not publicly available.
Can I buy Kali Therapeutics stock?
Kali Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Kali Therapeutics's last funding round?
Kali Therapeutics's most recent funding round was Strategic on March 23, 2026.
Who are the main investors in Kali Therapeutics?
Key investors in Kali Therapeutics include LYFE Capital.
Will Kali Therapeutics IPO soon?
No public IPO plans have been announced for Kali Therapeutics.
How can I track Kali Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Kali Therapeutics's shares on secondary markets.